Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from FDA

Maharashtra FDA suspends food licences of 3 Mumbai restaurants over hygiene issues

Mumbai FDA suspended three restaurant licenses due to serious food safety violations. Inspections revealed significant hygiene issues despite prior warnings and opportunities. Shalimar Hospitality, Noor Mohammadi Hotel, and Rehmania Restaurant faced immediate action. These establishments had multiple deficiencies including poor sanitation and improper storage. The FDA will continue strict enforcement…

The Economic Times

DNA tests find blackchin tilapia in cans

DNA tests have confirmed that fish found in canned products seized from a factory in Samut Sakhon were blackchin tilapia, an invasive species, rather than Nile tilapia as the government previously claimed, opposition lawmakers and the BioThai Foundation said on Tuesday.

Bangkok Post

Trust in the FDA is collapsing. It's time to get really transparent about our food and our drugs

Patients with no other options are watching an agency turn on its own scientists — and the trust that took a century to build is draining out in two years.

Fortune

From analysis to the latest developments in health,
read the most diverse news in one place.

A Bacterium from Japanese Tree Frogs Wiped Out Colorectal Tumors in Mice with a Single Dose

Scientists found that Ewingella americana from Japanese tree frogs eliminated 100% of colorectal tumors in mice with a single dose, outperforming chemo and immunotherapy. Pre-clinical only.

Medical Daily

GLP-1 Drugs Like Ozempic and Wegovy May Be Improving a Painful Skin Disease, Dermatologists Say

New evidence links GLP-1 drugs like Ozempic and Wegovy to significant improvements in psoriasis and hidradenitis suppurativa. Dermatologists explain what the data show and who may benefit.

Medical Daily

Kimbap, Pounded Yam, and Specialty Foods: Why Imported and Niche Grocery Recalls Deserve More Attention

Grocery Coupon Guide

RFK Jr’s advisory panel overhaul stalled update on helping kids quit tobacco

US preventive services taskforce’s members have not issued binding recommendations since March 2025

The Guardian - US

Read news from The Economist, FT, and more,
with one subscription

FDA approves at-home starter dose of Eisai-Biogen Alzheimer's drug

The US FDA approved an at-home starting dose for Eisai and Biogen's Alzheimer's drug. This new subcutaneous formulation allows patients to self-administer injections, improving access. Previously, patients received intravenous infusions, typically at clinics, for initial treatment. This approval differentiates Leqembi from competitor Kisunla's infusion-only requirement. The drug targets amyloid beta…

The Economic Times

New Analysis Links Wegovy to a Rare Eye Condition That Can Cause Sudden, Permanent Vision Loss

A March 2026 analysis of 30M+ FDA adverse event reports found Wegovy's NAION eye stroke signal was nearly 5x stronger than Ozempic's. Vision loss may be sudden and permanent.

Medical Daily

FDA Set to Decide on a New Non-Stimulant ADHD Drug for Children and Adults on July 24

FDA decides on centanafadine July 24, 2026 — a first-in-class non-stimulant ADHD drug for children, adolescents, and adults. Four Phase 3 trials support the application.

Medical Daily

There’s one reason why so many cold and flu tablets don’t actually work

You’ve got the sniffles and your nose is running like a tap. The tissues feel like sandpaper.

The Conversation

Can Removing "Zombie Cells" Slow Aging? Human Clinical Trials Are Starting to Deliver Answers

Senolytics — drugs that selectively eliminate senescent cells — have moved from mouse experiments to human clinical trials across kidney disease, Alzheimer's, and frailty. Here is an honest account of what 80-plus trials are finding.

Medical Daily

The First Human Trial to Reverse Aging Just Got FDA Clearance: What Epigenetic Reprogramming Actually Is

Harvard geneticist David Sinclair's Life Biosciences received FDA approval in January 2026 to begin the world's first human trial of partial epigenetic reprogramming — a technology that has already reversed aging in mouse and primate eyes. Here is what the science actually shows, and what it does not yet prove.

Medical Daily

A Breast Cancer Drug Decision Due July 17 Could Open a New Treatment Path for 37,000 Women a Year Who Have No Good Options Now

FDA decides on gedatolisib July 17, 2026, for HR+/HER2-/PIK3CA wild-type advanced breast cancer. A Phase 3 trial showed 76% risk reduction in progression. 37,000 patients per year.

Medical Daily

Get all your
news in one place.

100's of premium titles.
One news app.

The Economic Times

"40% Analog paneer samples found unsafe," says MH FDA Commissioner Tukaram Mundhe

Maharashtra FDA is intensifying action against adulterated milk products. Milk and dairy items are considered high-risk food categories requiring strict monitoring. The FDA is implementing end-to-end supply chain management for milk products. Action includes closing centers, destroying milk, and prosecuting violators. Substandard analog paneer and cheese also face strict regulatory…

The Guardian - UK

Olly Robbins launches legal challenge to dismissal as Foreign Office chief by Keir Starmer

Ex-FCDO top civil servant says he was given ‘irrational’ reasons for firing amid Peter Mandelson vetting scandal

Medical Daily

CDC Confirms 843 Cyclospora Cases Across 31 States as Michigan Outbreak Surpasses 1,500 Reports

CDC confirms 843 Cyclospora cases in 31 states as of July 9, 2026, with Michigan reporting 1,562 alone. No food source identified. Summer season continues.

Evening Standard

Olly Robbins launches legal fight against sacking as top Foreign Office mandarin

The FDA Union, representing Sir Olly, said Sir Keir Starmer should ‘admit that sacking Olly was a mistake’

Get all your
news in one place.

100's of premium titles.
One news app.

Roll Call

Defense funding to research troops’ brain injuries shrank since 2025

Funding for Defense Department medical research into traumatic brain injuries has dropped by more than three-quarters in the last three fiscal years, even as the problem continues to plague U.S. servicemembers. At issue is the Pentagon-funded program to research detection and treatment of TBIs and to understand psychological health issues,…

The Economic Times

Maharashtra FDA bars sale of two Cadila drugs over branding concerns

Maharashtra FDA has seized Cadila Pharmaceuticals drug stock worth Rs 2.45 crore. The action was taken due to similar branding on different active ingredients. Officials barred sales of Aciloc 150 Plus and Aciloc 300 Plus medicines. This move aims to prevent medication errors and safeguard public health. Further investigation and…

Medical Daily

Scientists Cracked the Bacterial Code Behind Powerful Anti-Cancer Drugs, and It Could Help Build Better Ones

Researchers decoded how bacteria naturally produce multiple anti-cancer drug variants, a Nature Communications finding that could accelerate development of improved cancer therapies.

Medical Daily

Contaminated Eye Drops? Recent Recalls Raise New Questions About How Sterility Failures Can Threaten Vision

A nationwide recall of millions of prescription eye drops highlights how sterility failures and contamination can threaten vision and eye health.

Grocery Coupon Guide

The New FDA Food Traceability Rules Could Change the Way Grocery Recalls Reach Your Family

Foodborne illness outbreaks create panic for consumers trying to protect their families from dangerous groceries. Historically, tracing a contaminated head of lettuce back to the original farm took several agonizing weeks. The federal government recently finalized strict new traceability rules to completely modernize the national food supply. These regulations require…

International Business Times UK

Cyclosporiasis Outbreak Passes 1,400 Cases as Investigators Admit They Still Can't Trace the Source

A bleach-resistant parasite has sickened more than 1,400 people across Michigan and Ohio. Officials still can't trace the source, and standard stool tests miss it entirely.

Medical Daily

Nara Organics Formula Recall: Infant Botulism Cases Rise to 4, FDA Confirms Pathogen in Open Can

Nara Organics infant formula botulism cases have risen to 4. FDA confirmed the bacteria in an open can. Parents should discard the product immediately.

1 … 7 8 9 10

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Nature Communications

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.